文献速递间质性肺疾病

标准化慢性过敏性肺炎暴露问卷的临床效用

Clinical utility of a standardized chronic hypersensitivity pneumonitis exposure questionnaire.
PubMed 文献 · Respirology · 2022-11-06

结果显示,33%的慢性过敏性肺炎患者通过问卷识别出临床医生未发现的暴露,其中63%为暂定低诊断信心者;问卷报告的暴露特征有助于提高诊断信心并减少抗原未定型慢性过敏性肺炎的比例。

要点

  • 标准化问卷可识别临床医生未发现的暴露,尤其在暂定低诊断信心的慢性过敏性肺炎患者中。
  • 慢性过敏性肺炎患者报告避免暴露后症状改善的可能性是非HP间质性肺病患者的3.5倍(p=0.004)。
  • 慢性过敏性肺炎患者报告每日频繁暴露的可能性是非HP间质性肺病患者的2.3倍(p=0.018)。

核心结论

  • 标准化暴露问卷可提高慢性过敏性肺炎的诊断信心并减少抗原未定型慢性过敏性肺炎的比例。

研究设计与样本

  • 参与者完成先前开发的标准化慢性过敏性肺炎暴露问卷,并与多学科会议数据(诊断、诊断信心、临床医生发现的暴露)一起收集。

主要发现

  • 在33%的慢性过敏性肺炎参与者中,标准化问卷识别出临床医生未发现的暴露。
  • 上述33%中63%为暂定低诊断信心慢性过敏性肺炎,暴露史本可提高这些病例的诊断信心。
  • 使用标准化问卷,96%的慢性过敏性肺炎参与者报告任何暴露,而非HP间质性肺病参与者为75%。
  • 慢性过敏性肺炎参与者报告避免暴露后症状改善的可能性是非HP间质性肺病参与者的3.5倍(p=0.004)。
  • 慢性过敏性肺炎参与者报告每日频繁暴露的可能性是非HP间质性肺病参与者的2.3倍(p=0.018)。

临床怎么用

  • 在慢性过敏性肺炎评估中可使用标准化暴露问卷辅助识别暴露并提升诊断信心。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Identification of an exposure is integral to the diagnosis, management, and prognostication of chronic hypersensitivity pneumonitis (CHP). Standardized questionnaires may aid in the identification of exposures, however, there currently are no evidence-based patient-validated questionnaires available. Key qualifiers (including duration and frequency) which indicate exposure relevance are also poorly defined. This study assessed the use of a standardized CHP exposure questionnaire in the identification of exposures and diagnostic confidence of CHP. METHODS: People with a multi-disciplinary meeting (MDM) diagnosis from five Australian interstitial lung disease (ILD) expert centres who provided informed consent were included. Participants completed a previously developed standardized CHP Exposure Questionnaire. Responses were collected with the participant's MDM data, including diagnosis, diagnostic confidence, and clinician-elicited exposures. RESULTS: One hundred thirty participants (IPF = 58, CHP = 24, CTD-ILD = 17, unclassifiable = 19, other = 12) were included. In 33% of CHP participants, a standardized questionnaire elicited an exposure where the clinician did not. 63% of these had provisional low confidence CHP; and an exposure history would have increased the diagnostic confidence in these cases. Using the standardized questionnaire, 96% of CHP participants reporting any exposure, compared with 75% of non-HP ILD participants. CHP participants were 3.5 times more likely (p = 0.004) to report their symptoms improved on avoidance, and 2.3 times more likely (p = 0.018) to report daily frequent exposure, compared with non-HP ILDs. CONCLUSION: A standardized questionnaire which elicits exposure characteristics in addition to presence or absence of relevant exposures can increase the diagnostic confidence of CHP and reduce the proportion of antigen-indeterminate CHP.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Barnes H, Chambers D, Grainge C, et al. Clinical utility of a standardized chronic hypersensitivity pneumonitis exposure questionnaire. Respirology. 2022. PMID: 36336654. doi:10.1111/resp.14404

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。